Every quarter in 2024 was better than the last. M&A ended the year on a strong, positive note, with the industrials and TMT ...
17h
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results